Medical News

RSS

Biodel seeks FDA marketing approval for VIAject

Biodel Inc. announced today that the U.S. Food and Drug Administration has accepted for review the company’s new drug application (NDA) seeking approval to market VIAject® for the treatment of diabetes. VIAject® is Biodel's proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs.

1 Mar 2010

FDA accepts for filing VIVUS' Qnexa NDA

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010.

1 Mar 2010

CellTrust to showcase secure mobile healthcare solution at HIMSS

CellTrust Corporation, the world's largest provider of SecureSMS for mobile phones, announced today its strategy to partner with Healthcare Provider Portals to bring secure mobile messaging solutions to companies across the healthcare industry, by the third quarter of 2010.

1 Mar 2010

Bruker BioSpin launches new 300 MHz high-resolution NMR spectrometer

Bruker BioSpin announces the new Fourier 300, an innovative, easy-to-use 300 MHz high-resolution spectrometer that brings Fourier transform (FT) Nuclear Magnetic Resonance (NMR) spectroscopy within every chemist’s reach. With its robust Fourier Probe technology, easy software, miniaturized electronics and proven magnets, the Fourier 300 is a complete proton and carbon 1D and 2D FT-NMR system that delivers powerful performance at an attractive price.

1 Mar 2010

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of the SUmiT Trial of its Urgent® PC Neuromodulation System that will be published in the April 2010 print edition of THE JOURNAL OF UROLOGY® and is now available on line.

1 Mar 2010

Xerox to manage all document and business process needs within healthcare organization

The recent acquisition of Affiliated Computer Services, Inc. makes Xerox Corporation the largest provider to manage all document and business process needs within a healthcare organization – from clinical and operational to financial and administrative.

1 Mar 2010

ATS Medical: First human robot assisted endoscopic aortic valve replacement in the Midwest

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first human robot assisted endoscopic aortic valve replacement in the Midwest using the daVinci® Surgical System from Intuitive Surgical to implant the ATS 3f ® Aortic Bioprosthesis. The procedure was recently performed by Husam H. Balkhy, M.D., at the Wisconsin Heart Hospital in Milwaukee, Wisconsin.

1 Mar 2010

Hospital staff request Ontario government to fund $8M deficit of Cornwall Community Hospital

The Ontario government should fully fund the $8 million deficit of the Cornwall Community Hospital, hospital staff will request today, as they rally at lunchtime at the McConnell site. The rally is organized by CUPE Local 7811, which represents 600 nurses, clerical, maintenance, cleaning, dietary and support staff at the Cornwall Community Hospital.

1 Mar 2010

Lumetra PSO to distribute iSOFT’s AIMS incident management software in the U.S. market

iSOFT Group Limited, one of the world’s largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT’s AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.

1 Mar 2010

Phytotechnologies can bring about much needed holistic approach

Phytotechnologies to Promote Sustainable Land Use Management and Improve Food Chain Safety - has just ended but the international community is still active and eager to maintain the vitality of this network.

1 Mar 2010

First Edition: March 1, 2010

Today's headlines focus on Democratic vote-counting and what plans the future will hold for advancing health reform.

1 Mar 2010

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

1 Mar 2010

Consumption of animal products contaminated with mycotoxins affects human health

EUREKA project E! 3025 MONALISA has developed a new, completely natural alternative to using antibiotics in animal feed. Formerly used as growth promoters and to prevent the damaging effects of the fungal toxins which are often present in feed, antibiotics have been prohibited for use in animal feed in the EU since 2006 - creating a need for a new, effective antimycotoxic agent.

1 Mar 2010

Astellas Pharma to acquire OSI Pharmaceuticals for $3.5 billion on fully diluted basis

Astellas Pharma Inc., a global pharmaceutical company, will commence a tender offer to acquire all outstanding shares of common stock of OSI Pharmaceuticals for $52.00 per share in cash, or an aggregate of approximately $3.5 billion on a fully diluted basis.

1 Mar 2010

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Bayer HealthCare Pharmaceuticals announced today that RECOTHROM(R) (Thrombin alfa (Recombinant)), the first recombinant, plasma-free thrombin approved by Health Canada, is now available for use as a topical hemostatic solution. According to a recent clinical study, RECOTHROM(R) was found to successfully stop 80 per cent of surgical bleeding within three minutes and 95 per cent of bleeding within 10 minutes.

1 Mar 2010

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Responding to the cardiac CT market’s need for superior image quality with lower radiation doses, Toshiba America Medical Systems, Inc., has unveiled new cardiac software enhancements available now for the Aquilion® ONE and Aquilion Premium CT systems. The new cardiac CT software package is designed to reduce radiation exposure while maintaining outstanding image quality.

1 Mar 2010

Elsevier to present tactical solutions for advancing healthcare quality at HIMSS 2010

Advancing healthcare quality to help improve patient outcomes and economic efficiency continues to be a primary focus in 2010 for Elsevier, the leading publisher of scientific, technical and medical information. During HIMSS 2010 (Atlanta, GA, March 1-3), Elsevier Clinical Decision Support will feature solutions that directly impact the quality of care, including evidence-based clinical content and tools; interdisciplinary documentation, planning and guidelines; drug decision support; interactive skills and procedures; data mining and outcomes analysis; and eLearning.

1 Mar 2010

Solta Medical acquires Aesthera

Solta Medical, Inc., a global leader in the medical aesthetics market, today announced the successful completion of its acquisition of Aesthera Corporation.

1 Mar 2010

Alere Health's chief officer to discuss factors essential to create most effective health ecosystem

Noting that most people are struggling with information overload and confusion when it comes to the nation's disparate and complex healthcare system, Gordon Norman, M.D., chief innovation officer for Alere Health, LLC, will highlight a range of attainable solutions at the 10th annual Population Health & Disease Management Colloquium to be held February 28 – March 2 in Philadelphia.

1 Mar 2010

Pangu BioPharma's naturally occurring splice variants of human tRNA synthetases study awarded second grant

The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.

1 Mar 2010

Medical News

Biodel seeks FDA marketing approval for VIAject

FDA accepts for filing VIVUS' Qnexa NDA

CellTrust to showcase secure mobile healthcare solution at HIMSS

Bruker BioSpin launches new 300 MHz high-resolution NMR spectrometer

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Xerox to manage all document and business process needs within healthcare organization

ATS Medical: First human robot assisted endoscopic aortic valve replacement in the Midwest

Hospital staff request Ontario government to fund $8M deficit of Cornwall Community Hospital

Lumetra PSO to distribute iSOFT’s AIMS incident management software in the U.S. market

Phytotechnologies can bring about much needed holistic approach

First Edition: March 1, 2010

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

Consumption of animal products contaminated with mycotoxins affects human health

Astellas Pharma to acquire OSI Pharmaceuticals for $3.5 billion on fully diluted basis

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Elsevier to present tactical solutions for advancing healthcare quality at HIMSS 2010

Solta Medical acquires Aesthera

Alere Health's chief officer to discuss factors essential to create most effective health ecosystem

Pangu BioPharma's naturally occurring splice variants of human tRNA synthetases study awarded second grant

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News